ATE526956T1 - Viruzide zusammensetzungen - Google Patents

Viruzide zusammensetzungen

Info

Publication number
ATE526956T1
ATE526956T1 AT02720972T AT02720972T ATE526956T1 AT E526956 T1 ATE526956 T1 AT E526956T1 AT 02720972 T AT02720972 T AT 02720972T AT 02720972 T AT02720972 T AT 02720972T AT E526956 T1 ATE526956 T1 AT E526956T1
Authority
AT
Austria
Prior art keywords
composition
treating
viruses
inflammation
effective
Prior art date
Application number
AT02720972T
Other languages
English (en)
Inventor
Thomas W Konowalchuk
Jack Konowalchuk
Original Assignee
Thomas W Konowalchuk
Jack Konowalchuk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas W Konowalchuk, Jack Konowalchuk filed Critical Thomas W Konowalchuk
Priority claimed from PCT/US2002/004273 external-priority patent/WO2002069887A2/en
Application granted granted Critical
Publication of ATE526956T1 publication Critical patent/ATE526956T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02720972T 2001-02-28 2002-02-13 Viruzide zusammensetzungen ATE526956T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/795,279 US7399790B2 (en) 2001-02-28 2001-02-28 Virucidal compositions
US10/016,189 US7045548B2 (en) 2001-02-28 2001-12-06 Methods of inactivating viruses
US10/021,533 US7268163B2 (en) 2001-02-28 2001-12-06 Method for treating an inflammation or lesion caused by a virus
US10/016,282 US7902258B2 (en) 2001-02-28 2001-12-06 Methods for preventing lesions caused by viruses of the Herpesviridae or Poxviridae family
PCT/US2002/004273 WO2002069887A2 (en) 2001-02-28 2002-02-13 Virucidal compositions

Publications (1)

Publication Number Publication Date
ATE526956T1 true ATE526956T1 (de) 2011-10-15

Family

ID=25165163

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02720972T ATE526956T1 (de) 2001-02-28 2002-02-13 Viruzide zusammensetzungen

Country Status (4)

Country Link
US (8) US7399790B2 (de)
KR (1) KR20040038908A (de)
AT (1) ATE526956T1 (de)
IL (1) IL157596A (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173709B2 (en) 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
WO2002037426A1 (en) * 2000-11-06 2002-05-10 United States Postal Service Remote mailbox management system and method
US7399790B2 (en) * 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
KR20050010914A (ko) * 2002-06-13 2005-01-28 가부시키가이샤 호오도 항균제 및 항균성 조성물
EP1639971B1 (de) * 2003-04-11 2012-10-24 Hououdou Co. Ltd. Zusammensetzungen zum schutz der haut
US20060075922A1 (en) * 2004-08-26 2006-04-13 Supik Albert P Controlled-acidity composition
EP1819222A2 (de) * 2004-12-09 2007-08-22 The Dial Corporation Zusammensetzungen mit hoher antiviraler und antibakterieller wirkung
EP1827099A2 (de) * 2004-12-09 2007-09-05 The DIal Corporation Zusammensetzungen mit starker antiviraler und antibakterieller wirksamkeit
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
MX2007006862A (es) * 2004-12-09 2008-02-15 Dial Corp Composiciones que tienen alta eficacia antiviral y antibacterial.
CA2588794A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
US9629361B2 (en) 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
US20070185216A1 (en) 2006-02-09 2007-08-09 Marcia Snyder Antiviral method
US8119115B2 (en) 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US8450378B2 (en) * 2006-02-09 2013-05-28 Gojo Industries, Inc. Antiviral method
CA2652818A1 (en) * 2006-05-24 2007-12-06 The Dial Corporation Composition and method for controlling the transmission of noroviruses
US20070274926A1 (en) * 2006-05-26 2007-11-29 The Dial Corporation Method of inhibiting the transmission of viruses
CA2653380A1 (en) 2006-05-30 2007-12-13 The Dial Corporation Compositions having a high antiviral efficacy
CA2653347A1 (en) * 2006-05-31 2007-12-13 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
WO2008036134A2 (en) 2006-06-02 2008-03-27 The Dial Corporation Method of inhibiting the transmission of influenza virus
WO2007145886A2 (en) * 2006-06-05 2007-12-21 The Dial Corporation Methods and articles having a high antiviral and antibacterial efficacy
US20080058421A1 (en) * 2006-09-05 2008-03-06 John Alex Lopes Compositions for cleaning and disinfecting nasal tract and sinus cavity
WO2008061375A1 (en) * 2006-11-24 2008-05-29 Germiphene Corporation Antiseptic
US20090062391A1 (en) * 2007-08-27 2009-03-05 Kent Christopher New Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds
US8389583B2 (en) 2008-05-23 2013-03-05 Zurex Pharma, Inc. Antimicrobial compositions and methods of use
US9744125B2 (en) * 2010-01-15 2017-08-29 Nuance Health, Llc Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US10039792B1 (en) 2013-03-16 2018-08-07 Brahm Holdings, Llc Methods for the treatment of inflammation and pain using human birth tissue material composition
US11571455B2 (en) 2013-04-11 2023-02-07 Vanderbilt University Methods and compositions for treating alcoholic liver disease
KR20190102898A (ko) * 2018-02-27 2019-09-04 지에스칼텍스 주식회사 2,3-부탄디올을 유효성분으로 포함하는 조성물
JP2022501337A (ja) * 2018-09-14 2022-01-06 ヴァンダービルト ユニヴァーシティ 皮膚疾患を治療するための方法および組成物
WO2021252954A2 (en) * 2020-06-12 2021-12-16 Schossau Tom M Inactivation of genome enveloped within coronavirus spherical or pleomorphic particles or shells to form a vaccine
KR20220039115A (ko) * 2020-09-21 2022-03-29 지에스칼텍스 주식회사 2,3-부탄다이올을 포함하는 조성물

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975217A (en) 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US4647458A (en) 1981-09-25 1987-03-03 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Liquid bactericide for foods and food processing machines or utensils, employing a synergistic mixture of ethyl alcohol, an organic acid and phosphoric acid
US4513008A (en) 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
CA1221640A (en) * 1984-03-07 1987-05-12 Nicola Pamukoff Pharmaceutical compositions for treating viral infections
GB8604986D0 (en) 1986-02-28 1986-04-09 Unilever Plc Disinfectant compositions
DE3622089A1 (de) 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US5405602A (en) 1989-01-31 1995-04-11 Simmons; Paul L. Nonaqueous cold sterilant
US5071650A (en) 1990-06-04 1991-12-10 Miles Inc. Use of intermediate length alcohols as virucidal agents in solutions of biologically active proteins
DE4205828A1 (de) 1992-02-26 1993-09-02 Henkel Kgaa Viruswirksame desinfektionsmittel
US5417968A (en) * 1993-08-16 1995-05-23 International Laboratory Technology Corp. Antimicrobial barrier composition
US6034133A (en) 1993-11-05 2000-03-07 The University Of Virginia Patents Foundation Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
DE69435067T2 (de) 1993-12-13 2008-05-15 Avanir Pharmaceuticals, La Jolla Formulierungen aus n-docosanol und saccharoseestern
US5492932A (en) 1994-02-22 1996-02-20 Kundsin Leduc Lenmark, Inc. Lubrication germicidal composition
US5767163A (en) 1994-02-22 1998-06-16 Kundsin Leduc Lenmark Inc. Lubricating and/or germicidal composition
US5512200A (en) 1994-04-18 1996-04-30 Thomas G. Bongard Low pH Acidic Compositions
SE9403541L (sv) 1994-10-14 1996-04-15 Sven Moberg Antimikrobiell komposition
US6197743B1 (en) 1996-07-26 2001-03-06 The Trustees Of Boston University Compositions and methods for the treatment of viral disorders
US5952392A (en) 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
JPH1187290A (ja) * 1997-09-10 1999-03-30 Hitachi Ltd 半導体基板の洗浄方法及びそれを用いた半導体装置の製造方法
KR20010043866A (ko) 1998-06-01 2001-05-25 안쏘니 제이. 버비스카 국소용 경피 치료제
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US6350724B1 (en) 1999-04-20 2002-02-26 Effcon Laboratories, Inc. Lice removing composition
US7399790B2 (en) 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
WO2002069887A2 (en) 2001-02-28 2002-09-12 Konowalchuk Thomas W Virucidal compositions
US7279163B1 (en) 2002-03-21 2007-10-09 The United States Of America, As Represented By The Secretary Of Agriculture Water-in-oil emulsion vaccines
PA8575901A1 (es) 2002-07-18 2004-07-20 Pfizer Prod Inc Derivados de piperidina novedosos
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US8158391B2 (en) 2009-05-06 2012-04-17 Dna Twopointo, Inc. Production of an α-carboxyl-ω-hydroxy fatty acid using a genetically modified Candida strain
US9327029B2 (en) 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds

Also Published As

Publication number Publication date
KR20040038908A (ko) 2004-05-08
US8901172B2 (en) 2014-12-02
US8853272B2 (en) 2014-10-07
US20120315341A1 (en) 2012-12-13
US20060210648A1 (en) 2006-09-21
US20020161046A1 (en) 2002-10-31
US7902258B2 (en) 2011-03-08
US20150190355A1 (en) 2015-07-09
US7045548B2 (en) 2006-05-16
US20020165278A1 (en) 2002-11-07
IL157596A (en) 2012-02-29
US9737498B2 (en) 2017-08-22
US7981933B2 (en) 2011-07-19
US7399790B2 (en) 2008-07-15
US20120093945A1 (en) 2012-04-19
US20020165277A1 (en) 2002-11-07
US20020165279A1 (en) 2002-11-07
US7268163B2 (en) 2007-09-11

Similar Documents

Publication Publication Date Title
ATE526956T1 (de) Viruzide zusammensetzungen
US4381296A (en) Treatment for herpes virus
US4285934A (en) Treatment for herpes virus
US5455033A (en) Medicinal composition for treatment of inflammation
MXPA03007748A (es) Composiciones que destruyen virus.
ATE214931T1 (de) Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen
PE20001032A1 (es) Composiciones y metodos para tratar enfermedades pulmonares
DE60034667D1 (de) Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
WO2003004098A8 (en) Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
WO2002009637A3 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
JPH10513193A (ja) ヘルペスを処置するための医薬組成物
US5571535A (en) Treatment of topical infections
DK284386D0 (da) Farmaceutisk praeparat mod hudlidelser
HRP20130071T1 (hr) Poboljšani testosteron u gelu i naäśin primjene
WO2007022509A3 (en) Use of seh inhibitors as analgesics
JP6026540B2 (ja) 種々の原因の末梢性潰瘍の治療用組成物
JP2001240547A (ja) 花粉症抑制剤
US20080076831A1 (en) Hemorrhoid reliever and method of use
NO975726L (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
DK0988033T3 (da) Anvendelse af dichlorbenzylalkohol til fremstilling af et præparat til topisk behandling af inflammation
JPH01294635A (ja) 局所投与用製薬組成物
ATE271896T1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
WO2011035120A3 (en) Therapeutic composition to treat lesions caused by herpes simplex virus
EP2598132A1 (de) Zusammensetzung zur behandlung und prävention von herpes simplex labialis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties